Sign up to save your podcasts
Or
Share "QR (Mannitol) Cream for Chronic Pain" with Dr. Helene Bertrand and Dr. Marylene Kyriazis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
"QR (Mannitol) Cream for Chronic Pain" with Dr. Helene Bertrand and Dr. Marylene Kyriazis
Dr. Marylene Kyriazis
Dr. Marylene is a Doctor of Pharmacy and has served as a community and consultant clinical pharmacist for more than 25 years. Since 2010, she has focused on palliative care and pain management. Her roles include consultant, mentor, product and program developer, public speaker, researcher and philanthropist. She developed a CCCEP accredited certificate program in pain management and mentored community pharmacists across the province of BC. She was involved in the research and development of QR Cream™. She has volunteered in numerous capacities as a committee and board member for professional and philanthropic organizations. She is currently the Co-Founder, President and CEO of the Paul Sugar Palliative Support Foundation, providing supportive care to patients with a serious illness and their families. As a Director of MaryHelene Enterprises Inc., she is responsible for the manufacturing, marketing and distribution of QR Cream™.
Dr. Helene Bertrand
Main interest is relieving pain. To provide pain relief she uses prolotherapy. She has published a paper on using prolotherapy for shoulder pain (PM&R 2016 January 2016). She also uses perineural injections and has invented a cream for topical pain treatment. A randomized controlled study has proven the effectiveness of this cream for pain relief (PM&R November 7 2015). She has completed a pilot study on using this cream for postherpetic neuralgia: 16 of the 20 people suffering from pain following a bout the shingles, on average five years previously, found relief from this cream. She is conducting a randomized placebo-controlled study using it for painful diabetic peripheral neuropathy. The study is underway with, currently, 81 of the 90 participants needed. As she has started selling the cream, the principal investigator is Dr. François Louw from Kelowna. The cream provides on average 53% pain relief (narcotics, 36%, anti-inflammatories, 23%, Tylenol 13%). To find out more about the cream, called QR cream, go to www.qrcream.com. She has developed a new way to examine for and treat low back pain which provides 78% of those examined with pain relief using a two-minute exercise, see https://www.youtube.com/watch?v=NXNS6PNKRPo. She is about to start a randomized controlled study to assess the long-term effectiveness of this technique.
View all episodes
By Wayne PhimisterDr. Marylene Kyriazis
Dr. Marylene is a Doctor of Pharmacy and has served as a community and consultant clinical pharmacist for more than 25 years. Since 2010, she has focused on palliative care and pain management. Her roles include consultant, mentor, product and program developer, public speaker, researcher and philanthropist. She developed a CCCEP accredited certificate program in pain management and mentored community pharmacists across the province of BC. She was involved in the research and development of QR Cream™. She has volunteered in numerous capacities as a committee and board member for professional and philanthropic organizations. She is currently the Co-Founder, President and CEO of the Paul Sugar Palliative Support Foundation, providing supportive care to patients with a serious illness and their families. As a Director of MaryHelene Enterprises Inc., she is responsible for the manufacturing, marketing and distribution of QR Cream™.
Dr. Helene Bertrand
Main interest is relieving pain. To provide pain relief she uses prolotherapy. She has published a paper on using prolotherapy for shoulder pain (PM&R 2016 January 2016). She also uses perineural injections and has invented a cream for topical pain treatment. A randomized controlled study has proven the effectiveness of this cream for pain relief (PM&R November 7 2015). She has completed a pilot study on using this cream for postherpetic neuralgia: 16 of the 20 people suffering from pain following a bout the shingles, on average five years previously, found relief from this cream. She is conducting a randomized placebo-controlled study using it for painful diabetic peripheral neuropathy. The study is underway with, currently, 81 of the 90 participants needed. As she has started selling the cream, the principal investigator is Dr. François Louw from Kelowna. The cream provides on average 53% pain relief (narcotics, 36%, anti-inflammatories, 23%, Tylenol 13%). To find out more about the cream, called QR cream, go to www.qrcream.com. She has developed a new way to examine for and treat low back pain which provides 78% of those examined with pain relief using a two-minute exercise, see https://www.youtube.com/watch?v=NXNS6PNKRPo. She is about to start a randomized controlled study to assess the long-term effectiveness of this technique.